The phytotoxin albicidin is a novel inhibitor of DNA gyrase by Hashimi, SM et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2007, p. 181–187 Vol. 51, No. 1
0066-4804/07/$08.000 doi:10.1128/AAC.00918-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
The Phytotoxin Albicidin is a Novel Inhibitor of DNA Gyrase
Saeed M. Hashimi,1 Melisa K. Wall,2† Andrew B. Smith,2‡ Anthony Maxwell,2 and Robert G. Birch1*
Botany Department—SIB, The University of Queensland, Brisbane 4072, Australia,1 and Department of Biological Chemistry,
John Innes Centre, Norwich Research Park, Colney, Norwich NR4 7UH, United Kingdom2
Received 25 July 2006/Returned for modification 20 September 2006/Accepted 20 October 2006
Xanthomonas albilineans produces a family of polyketide-peptide compounds called albicidins which are
highly potent antibiotics and phytotoxins as a result of their inhibition of prokaryotic DNA replication. Here
we show that albicidin is a potent inhibitor of the supercoiling activity of bacterial and plant DNA gyrases, with
50% inhibitory concentrations (40 to 50 nM) less than those of most coumarins and quinolones. Albicidin
blocks the religation of the cleaved DNA intermediate during the gyrase catalytic sequence and also inhibits
the relaxation of supercoiled DNA by gyrase and topoisomerase IV. Unlike the coumarins, albicidin does not
inhibit the ATPase activity of gyrase. In contrast to the quinolones, the albicidin concentration required to
stabilize the gyrase cleavage complex increases 100-fold in the absence of ATP. The slow peptide poisons
microcin B17 and CcdB also access ATP-dependent conformations of gyrase to block religation, but in contrast
to albicidin, they do not inhibit supercoiling under routine assay conditions. Some mutations in gyrA, known
to confer high-level resistance to quinolones or CcdB, confer low-level resistance or hypersensitivity to albicidin
in Escherichia coli. Within the albicidin biosynthesis region in X. albilineans is a gene encoding a pentapeptide
repeat protein designated AlbG that binds to E. coli DNA gyrase and that confers a sixfold increase in the level
of resistance to albicidin in vitro and in vivo. These results demonstrate that DNA gyrase is the molecular
target of albicidin and that X. albilineans encodes a gyrase-interacting protein for self-protection. The novel
features of the gyrase-albicidin interaction indicate the potential for the development of new antibacterial
drugs.
Albicidins are potent antibiotics and phytotoxins produced
by the bacterial phytopathogen Xanthomonas albilineans.
Albicidins selectively block prokaryote DNA replication (9, 10)
and cause the characteristic chlorotic symptoms of sugarcane
leaf scald disease by blocking chloroplast development (8, 11).
They are pathogenesis factors with an important role in sys-
temic invasion of host plants (48, 49).
Albicidins are bactericidal at nanomolar concentrations
against a range of gram-positive and gram-negative bacteria,
are not cytotoxic at 10 M for cultured mammalian cells, and
hold the potential to be novel clinical antibiotics. The major
antimicrobial component produced in culture on rich media
has a molecular mass of 842 Da and has a structure containing
several aromatic rings (7). Biosynthesis involves a megasyn-
thase with polyketide and nonribosomal peptide synthetase
modules (26). Accessory proteins involved in synthesis and
resistance functions are substantially clustered in the X.
albilineans genome (24–26, 36).
Albicidin-resistant target mutants have not been obtained
previously due to a high background frequency of mutations to
resistance in Escherichia coli through changes to the Tsx nu-
cleotide uptake channel (12). Other albicidin resistance mech-
anisms include antibiotic binding, enzymatic detoxification,
and export (2, 14, 42, 48). Albicidins do not directly bind to or
damage DNA, and no cross-resistance with other DNA repli-
cation inhibitors has previously been identified. The speed and
specificity of inhibition of DNA replication by albicidin resem-
ble those of DNA gyrase-inhibiting coumarin and quinolone
antibiotics (10). In antibiotic checkerboard tests, there is slight
synergy between albicidin and coumermycin and a slight inter-
ference of albicidin with nalidixic acid (C. Rathus and R. G.
Birch, unpublished data).
Bacterial DNA gyrase is a topoisomerase with the unique
ability to negatively supercoil DNA. It operates as an A2B2
complex of GyrA and GyrB subunits (17). The catalytic cycle
for supercoiling involves the paired GyrA C-terminal domains
in wrapping the DNA substrate around the enzyme and secur-
ing a DNA sequence to be reversibly cleaved (the G segment)
by catalytic tyrosines in the GyrA N-terminal domains. The
DNA to be transported through this break is directed through
a series of three gates or clamps in the enzyme. In the resting
conformation, the entry gate comprising the GyrB N termini is
open, allowing entry of the transported DNA (T segment) into
the cavity above the closed DNA gate, which comprises the
GyrB C termini and the GyrA N termini with bound G-
segment DNA. Binding of ATP closes the entry gate, clamp-
ing the T segment onto the DNA gate, which opens tran-
siently to allow T-segment passage through the cleaved G
segment. The energy stored in the protein-DNA (phospho-
tyrosine) covalent linkage is sufficient to allow the rejoining
of the G segment, and ATP hydrolysis reopens the entry
gate. The T segment is released from the cavity below the
closed DNA gate through an exit gate, which is formed by
the interface of amino acids in the central region of the
paired GyrA peptides. ATP is essential for supercoiling, but
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strand passage can occur in the opposite direction for re-
laxation of supercoiled DNA without ATP.
Because its functions are essential in DNA replication, tran-
scription, and gene regulation, DNA gyrase has become an
important target for antibacterial antibiotics (22, 28). DNA
gyrase has recently been shown to be essential also in plant
organellar replication (15, 44). In this paper we show that
DNA gyrase is the molecular target of albicidin, which has
features of inhibition that differ from those of known antibiotic
classes.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and antibiotics. The bacterial strains and
plasmids used for this study are listed in Table 1. Escherichia coli cultures were
grown at 37°C in Luria-Bertani medium (37). Xanthomonas albilineans cultures
were grown at 28°C in SMG3 medium (50). Albicidins were purified to single
peaks by C18 high-pressure liquid chromatography, dissolved in methanol, and
quantified by bioassay for their activities against E. coli K-12 strain MG1665, as
described previously (12, 50). Under these growth conditions, earlier-eluting
albicidin ( peak) predominates over the compound ( peak) described from
complex media (7). They are closely related compounds, as indicated by their
nuclear magnetic resonance spectra and by equivalent responses to all known
albicidin resistance mechanisms, although the full structures have not yet been
elucidated (M. J. Garson and R. G. Birch, unpublished data). The high-pressure
liquid chromatography-purified -peak albicidin was used in all experiments
described here. Ciprofloxacin (Fluka) and novobiocin (Sigma) were dissolved in
water.
Gene cloning and characterization. The albG gene from X. albilineans with
flanking NdeI and BamHI sites was amplified by PCR with primers XaQnrF
(5-ATCAGGTTTCCACATATGCCGGCCAAGACCC-3) and XaQnrR (5-C
GGGATCCAGGTTGCATCAGTCACACG-3) (restriction sites are under-
lined). After digestion with NdeI and BamHI, the amplified fragment was cloned
into pET-19b to give pET19b-XaQnr, which contained an N-terminal His6 tag to
facilitate isolation of fusion proteins. Clones were tested for albicidin resistance
by a microbial plate bioassay described previously (10).
DNA sequencing was performed by dideoxynucleotide chain termination (38)
with a BigDye Terminator cycle sequencing kit (version 3.1) and a 373A DNA
sequencer (PE Applied Biosystems).
Enzyme assays. Unless specified, the DNA gyrase used was E. coli A2B2; the
DNA substrate was pBR322 in the supercoiled, relaxed, or EcoRI-linearized
form; and the assays were performed as described previously (20, 35, 39, 44). The
methanol concentration in the reactions for testing of the albicidin dilution series
was constant at 0.82% (vol/vol).
The gyrase supercoiling reaction mixtures (30 l), which contained gyrase (3.4
nM), 1 mM ATP, and 5 nM (0.4 g) relaxed pBR322 DNA, were incubated at
37°C for 30 to 60 min and then terminated by addition of 0.5 volume of STEB
(20% [wt/vol] sucrose, 0.05 M Tris · HCl [pH 7.5], 0.05 M EDTA, 50 g ml1
bromophenol blue) and 2 volumes of chloroform-isoamyl alcohol (24:1), fol-
lowed by electrophoretic analysis in 1% agarose gels. The 50% inhibitory
concentrations (IC50s) for drug inhibition were determined as described
previously (20).
Gyrase relaxation assays were performed similarly to the supercoiling assays,
except that ATP and spermidine were omitted, the enzyme concentration was 10
nM, the substrate was supercoiled pBR322 DNA, and the samples were incu-
bated at 37°C for 4 h. Relaxation assays catalyzed by topoisomerase IV were
carried out by incubating enzyme (5 nM) and supercoiled pBR322 DNA (5 nM)
with various concentrations of drug in 40 mM HEPES · KOH (pH 7.6), 10 mM
magnesium acetate, 100 mM potassium glutamate, 10 mM dithiothreitol, 50 g
ml1 bovine serum albumin, 1 mM ATP, 4 g ml1 tRNA, 1% (wt/vol) glycerol,
2% (vol/vol) dimethyl sulfoxide.
The DNA cleavage reaction mixtures contained gyrase (34 nM), 5 to 12 nM
relaxed or supercoiled pBR322 DNA, 35 mM Tris · HCl (pH 7.5), 24 mM KCl,
4 mM MgCl2, 2 mM dithiothreitol, 1.8 mM spermidine, 0.1 mg ml1 bovine
serum albumin, 6.5% (wt/vol) glycerol, and various concentrations of drug in the
presence or the absence of 1 mM ATP or 5-adenylyl ,-imidodiphosphate
(ADPNP), a nonhydrolyzable ATP analog. Ciprofloxacin and CcdB were used at
5 M as positive controls for stabilization of cleavage complexes. Linear product
was released by the addition of sodium dodecyl sulfate (SDS) to 0.2% (wt/vol)
and proteinase K to 0.1 mg ml1, followed by incubation at 37°C for 30 min.
Cleavage specificity reactions were performed as described previously (1).
The gyrase ATPase reaction mixtures contained 20 M the N-terminal domain
of GyrB (GyrB43) in 47 mM Tris · HCl (pH 7.5), 1 mM EDTA, 6% (wt/vol)
glycerol, 26.6 mM KCl, 2 mM dithiothreitol, 5 mM MgCl2, 800 M phosphoenol-
pyruvate, 400 M NADH, 1% (vol/vol) pyruvate kinase-lactate dehydrogenase
enzymes (Sigma), and 2 mM ATP; and the reactions were carried out at 25°C.
For determination of the DNA-dependent ATPase activity, 70 nM gyrase was
incubated with 2.8 nM linear pBR322 DNA under the conditions described
above.
Qnr purification. E. coli Rosetta pLysS cultures containing pET19b-XaQnr
were grown at 37°C overnight. The starter cultures were inoculated at a 1:100
ratio into Luria-Bertani liquid medium containing ampicillin (100 g ml1) and
chloramphenicol (30 g ml1). The cultures were grown at 30°C with shaking
until they reached an optical density at 600 nm of 0.5. Isopropyl--D-thiogalac-
topyranoside (IPTG) was added to a final concentration of 1 mM, and the
cultures were grown at 30°C for 4 h. Bacterial cells were harvested by centrifu-
TABLE 1. Properties of strains and plasmids used in this study
Strain or plasmid Relevant characteristics Reference or source
Strains
E. coli
MG1665 K-12 type strain (wild-type GyrA and GyrB)
MLS83L Isogenic to MG1665 except for GyrA S83L, quinolone resistant W. M. Parks and A. Maxwell,
unpublished data
B410 Wild-type GyrA 4
B462 B410 GyrA R462C, CcdB resistant 4
HB101 Wild-type GyrB 13
CC6 HB101 GyrB R136C, coumarin resistant 16
CC7 HB101 GyrB R136S, coumarin resistant 16
Rosetta pLysS Novagen
X. albilineans
Xa13 Wild-type albicidin producer from sugarcane (Queensland), Apr 50
LS155 Wild-type albicidin producer from sugarcane (Queensland), Apr 43
Plasmids
pBluescript Expression vector, native protein, bla (Apr) Stratagene
pET-19b Expression vector, His6 fusion protein, bla (Ap
r) Invitrogen
pET19b-XaQnr pET-19b containing albG, Apr This study
pBR322 Substrate DNA for DNA gyrase assays 13
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gation at 6,000  g. Soluble proteins were released by incubation in 50 mM
Tris · HCl (pH 7.5), 1 mM EDTA, 10% (wt/vol) glycerol, 0.02% (wt/vol) ly-
sozyme, and 0.12% (wt/vol) Brij 35. The cell lysate was centrifuged at 100,000 
g for 1 h at 4°C; and the supernatant was dialyzed into 20 mM Tris · HCl (pH 7.5),
10% (wt/vol) glycerol, 150 mM NaCl, and 10 mM imidazole. The dialyzed lysate
was loaded onto a 5 ml HiTrap chelating HP Ni column (Amersham), and the
His-tagged protein was eluted with 600 mM imidazole. Fractions containing the
31-kDa protein were dialyzed into TGED buffer (44), flash frozen in liquid N2,
and stored at 80°C.
RESULTS
Albicidin inhibits gyrase-mediated DNA supercoiling. We
found albicidin to be a potent inhibitor of DNA supercoiling
catalyzed by E. coli DNA gyrase, with an IC50 value of 	40 nM
(Fig. 1A). It also inhibited DNA supercoiling mediated by
Arabidopsis thaliana mitochondrial and chloroplast gyrases,
with IC50s of 	50 nM (Fig. 1C and data not shown). Albicidin
inhibited the ATP-independent relaxation activity of E. coli
DNA gyrase with an IC50 value of 	600 nM (Fig. 2A) and the
ATP-dependent relaxation reaction of topoisomerase IV with
an IC50 value of 	300 nM (Fig. 2B). It also inhibited decat-
enation by topoisomerase IV but did not affect the ATPase
activity of DNA gyrase (data not shown).
Albicidin stabilizes the DNA gyrase cleavage complex in an
ATP-dependent manner. A number of agents, including quin-
olone drugs, CcdB, and microcin B17, can stabilize the cova-
lent complex formed between gyrase and DNA. After SDS-
proteinase K treatment, a linear DNA band in reaction
mixtures containing antibiotic, gyrase, and DNA indicates sta-
bilization of the gyrase-DNA cleavage complex (18, 28, 34).
We found that the yield of linear DNA reached a plateau with
an increasing albicidin concentration (Fig. 3). For convenience
in this section, we use CC50 to mean the antibiotic concentra-
FIG. 1. Albicidin-mediated inhibition of DNA supercoiling reac-
tions of DNA gyrases (3.4 nM) from E. coli MG1665 wild type (IC50
	40 nM) (A), E. coli with quinolone resistance-conferring gyrase mu-
tation GyrA S83W (IC50, 	200 nM) (B), and Arabidopsis thaliana
mitochondria (IC50, 	50 nM) (C). Lanes CFX, control treatment with
the known DNA gyrase inhibitor ciprofloxacin.
FIG. 2. Effect of albicidin on relaxation of supercoiled DNA
by topoisomerases E. coli DNA gyrase (10 nM) (A) and E. coli
topoisomerase IV (5 nM) (B). Controls were no enzyme (lanes ), no
drug (lanes ), and the known gyrase inhibitors ciprofloxacin (lanes
CFX) and novobiocin (lanes NOV).
FIG. 3. Ability of albicidin (Alb) to stabilize the gyrase-DNA cleav-
age complex in the presence or the absence of ATP or ADPNP and
with relaxed or supercoiled DNA substrate. O, open circle DNA; L,
linear DNA; C, closed circle DNA. The formation of linear DNA
indicates stabilization of the cleavage complex. The DNA gyrase con-
centration was 34 nM. The reaction mixtures for the control panel did
not include either ATP or ADPNP.
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tion required to obtain half of the maximum yield of linear
DNA observed in the reaction mixture containing albicidin,
gyrase, ATP, and DNA. Albicidin stabilized the cleavage com-
plex equally (CC50, 	30 nM) with relaxed or supercoiled sub-
strate in the presence of ATP and to a lesser extent (CC50,
	300 nM) in the presence of ADPNP. In the absence of ATP
or ADPNP, stabilization of the cleavage complex required a
much higher albicidin concentration (CC50, 	3,100 nM) when
supercoiled DNA was used as the substrate and, apparently, an
albicidin concentration at least an order of magnitude higher
with relaxed DNA substrate (Fig. 3).
Albicidin and ciprofloxacin induced similar fragmentation
patterns in linear pBR322 in the presence of DNA gyrase,
indicating no major effect on the site specificity for cleavage
(Fig. 4).
Cross-resistance to known gyrase mutations. Spontaneous
resistance to quinolone drugs commonly involves mutations
that change Ser83 of GyrA to Leu or Trp (28, 47). We found
that the E. coli quinolone-resistant strain MLS83L (GyrA
S83L) showed a four- to sixfold increase in resistance to albi-
cidin relative to that of its isogenic parent strain, MG1665, in
the antimicrobial assay (Fig. 5A). Similarly, the IC50 for albi-
cidin increased four- to sixfold with purified GyrA S83W en-
zyme relative to that with wild-type E. coli gyrase (Fig. 1B).
Spontaneous resistance to coumarin drugs commonly involves
mutations that alter Arg136 of GyrB (28). We found that
coumermycin-resistant mutants CC6 (GyrB R136C) and CC7
FIG. 5. (A) Albicidin cross-resistance by E. coli MG1665 and isogenic
quinolone-resistant strain MLS83L (GyrA S83L); (B) increased sensitivity
to albicidin resulting from the GyrA R462C (CcdB resistance) mutation in
E. coli B462 relative to isogenic parent strain B410; (C) decreased sensi-
tivity to albicidin in E. coli conferred by the albG gene from X. albilineans.
The results are means with standard errors from three replicates.
FIG. 4. Cleavage of linear pBR3222 by DNA gyrase in the presence
of ciprofloxacin (CFX) or albicidin (Alb). Lane M, molecular weight
markers; lane SC, supercoiled pBR322; lanes for controls without
antibiotic, linear pBR322 (lane 1), linear pBR322 extracted with phe-
nol (lane 2), and linear pBR322 treated with SDS-proteinase K (lane
3). Reactions including antibiotic were 5 M ciprofloxacin (lane 4), 10
M ciprofloxacin (lane 5), 40 nM albicidin (lane 6), and 100 nM
albicidin (lane 7).
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(GyrB R136S) showed no significant difference in their sensi-
tivities to albicidin relative to that of parent strain HB101 (data
not shown).
Mutations that change Arg462 of GyrA to Cys confer resis-
tance to CcdB (5). We found that E. coli B462 bearing this
mutation showed a twofold increased sensitivity to albicidin
compared with the sensitivities of its isogenic parent strain
(strain B410) and wild-type strain MG1655 (Fig. 5B). Similarly,
purified GyrA R462C protein showed twofold increased sen-
sitivity to albicidin in assays testing for inhibition of supercoil-
ing and for stabilization of the cleavage complex.
X. albilineans encodes a DNA gyrase-interacting protein (AlbG)
that confers increased resistance to albicidin. The albicidin bio-
synthetic gene cluster (36) contains a sequence that encodes a
predicted product with 30 to 40% similarity to the quinolone
resistance proteins Qnr and MfpA (32, 41). We cloned the X.
albilineans homolog (here designated albG) into both pBlue-
script and pET19b vectors. This conferred a 30-fold increase in
resistance to albicidin among E. coli cells grown without IPTG
induction in the case of the pBluescript clone and a 4- to 6-fold
increase in resistance in the case of the pET19b clone, which
encodes a His6-AlbG fusion (Fig. 5C), with no change in sen-
sitivity to ciprofloxacin (data not shown). Growth was inhibited
in the presence of IPTG (50 M). Purified His6-AlbG (0.65
M) protected gyrase from the effects of albicidin in super-
coiling assays, increasing the IC50 for albicidin by two- to four-
fold, with little or no effect on the sensitivity to ciprofloxacin. In
separate assays, His6-AlbG partially inhibited the supercoiling
activity of DNA gyrase in the absence of albicidin (IC50, 6 M)
without evidently inhibiting the cleavage of supercoiled DNA
by gyrase, which produces the linear DNA band in this assay
(18). This is similar to the action of the MfpA protein, which
mimics a B-form DNA and inhibits the supercoiling activity of
DNA gyrase (23).
DISCUSSION
The results presented in this paper show that albicidin is a
potent inhibitor of bacterial and plant organellar DNA gyrases
and has a mechanism that likely differs at the molecular level
from those of previously characterized gyrase-inhibiting anti-
biotics. For inhibition of supercoiling activity, the IC50 of albi-
cidin (50 nM) is less than those of ciprofloxacin (700 nM) and
novobiocin (250 nM) under the same conditions (20), and
albicidin is as effective against the plant (A. thaliana) chloro-
plast and mitochondrial DNA gyrases as it is against the bac-
terial (E. coli) enzyme (Fig. 1).
Significance of a gyrase-inhibiting phytotoxin. This is the
first example of a bacterial phytotoxin with a known molecular
target in plastid DNA replication. Other phytotoxins reported
to target host nucleic acid biosynthesis are targetitoxin, which
inhibits plastid RNA polymerase (40), and solanapyrone,
which inhibits a nuclear DNA polymerase (30). Albicidin pro-
duction probably serves a dual role for X. albilineans in its
niche as a wound-infecting, systemic xylem-invading sugarcane
pathogen. First, it is a potent antibiotic against secondary bac-
terial invaders. Interestingly, an albicidin detoxification gene
confers resistance in Pantoea dispersa, which is widely associ-
ated with plants (48), and an albicidin exporter homolog exists
in the genome of the sugarcane xylem-invading organism
Liefsonia xyli (31). Second, albicidin is important for systemic
invasion by X. albilineans, probably because interference with
plastid function reduces the capacity of the plant to mount
effective defense responses (6). Introduction of an organellar
albicidin-resistant gyrase is a possible means of engineering
plant resistance to sugarcane leaf scald disease.
Features of gyrase inhibition. The effects of albicidin on
reactions with purified enzymes are compared in Table 2. Un-
like the coumarins, which interact primarily with the region
around the GyrB binding site for ATP and function as com-
petitive inhibitors of the ATPase activity needed for gyrase
function (29), albicidin did not inhibit the ATPase activity of
DNA gyrase. Albicidin did inhibit the ATP-independent relax-
ation reaction of gyrase, albeit with a higher IC50 than that for
supercoiling, and it also inhibited ATP-dependent relaxation
and decatenation by the related enzyme topoisomerase IV
(Fig. 2B). Unlike quinolones, which apparently interact with
the N-terminal domain of GyrA and cause rapid ATP-inde-
pendent stabilization of the gyrase-cleaved DNA complex (21),
albicidin required the presence of ATP for efficient stabiliza-
tion of the complex (Fig. 3). In the absence of ATP, the CC50
values for cleavage increased from 30 nM by at least 100-fold
for supercoiled substrate DNA and at least 1,000-fold for re-
laxed substrate DNA.
The ATP-dependent stabilization of the gyrase-DNA cleav-
age complex by albicidin is reminiscent of the effects of the
plasmid-encoded peptides microcin B17 and CcdB. However,
these peptides are slow poisons, apparently because their op-
portunity to enter and bind within the gyrase complex is tran-
sient during the catalytic cycle, while the DNA gate is open in
the case of CcdB (19, 34, 39). As a result, they do not inhibit
gyrase-mediated supercoiling under the usual assay conditions.
For both microcin B17 and CcdB, dependence on ATP is
TABLE 2. IC50 and CC50 values for albicidin in reactions with
purified enzymes
Enzyme reaction Albicidin IC50or CC50 (nM)
DNA supercoiling by DNA gyrase from
wild-type E. coli ................................................................ 40
DNA supercoiling by DNA gyrase from
Arabidopsis plastids or mitochondria............................. 50
DNA supercoiling by DNA gyrase from
quinolone-resistant (GyrA S83L) E. coli ...................... 200
ATP-dependent relaxation by topoisomerase
IV from wild-type E. coli ................................................ 300
ATP-independent relaxation by DNA gyrase
from wild-type E. coli ...................................................... 600
ATPase activity of DNA gyrase from
wild-type E. coli ................................................................Not inhibited
Stabilization of cleavage complex between
DNA gyrase, relaxed or supercoiled DNA,
and ATP (CC50) ............................................................... 30
Stabilization of cleavage complex between
DNA gyrase, relaxed or supercoiled DNA,
and ADPNP (CC50) ......................................................... 300
Stabilization of cleavage complex between
DNA gyrase and supercoiled DNA without
ATP or ADPNP (CC50) .................................................. 3,100
Stabilization of cleavage complex between
DNA gyrase and relaxed DNA without
ATP or ADPNP (CC50) .................................................. 
30,000
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greater for cleavage of relaxed DNA than for cleavage of
supercoiled DNA (18, 33, 39). In contrast, albicidin proved to
be an efficient inhibitor of gyrase-mediated supercoiling (Fig.
1), and dependence on ATP was similar for stabilization of the
cleavage complex with relaxed and supercoiled substrate DNA
(Fig. 3).
Mechanism of gyrase inhibition by albicidin. Our results
indicate that albicidin (like quinolones) must efficiently access
and bind to its target sites within the gyrase complex without
the need for multiple catalytic cycles. This is consistent with the
small size of albicidins (molecular weight, 	842) relative to
those of the peptide poisons.
Interestingly, the nonhydrolyzed analogue ADPNP could
partially substitute for ATP in facilitating albicidin-mediated
stabilization of the gyrase-cleaved DNA complex, requiring an
approximately 10-fold higher albicidin concentration for an
effect equivalent to those required for reactions containing ATP
with either supercoiled or relaxed DNA substrates. ADPNP
apparently holds the entry gate of DNA gyrase in a closed
conformation, supporting only a single cycle of supercoiling
and slowing DNA relaxation (3, 46). The closing of the entry
gate by ATP or ADPNP may be important to bring the gyrase-
DNA complex into a conformation susceptible to action by
albicidin, as envisaged for quinolones (21). The more stringent
requirement for ATP by albicidin relative to that by quinolones
implies that a different target conformation is formed during
an ATP-mediated step in the supercoiling cycle. Albicidin may
interfere with religation of the G segment once the DNA gate
has opened. The absence of ATP in the relaxation assays may
reduce the occurrence of the enzyme conformation susceptible
to binding by albicidin. Analysis of albicidin binding to indi-
vidual gyrase domains and analysis of the kinetics of the effects
on gyrase reactions could help to elucidate the interaction.
Certain DNA gyrase mutants show albicidin resistance. Both
quinolone and CcdB resistance-conferring mutations in E. coli
altered the sensitivity to albicidin. Relative to the isogenic
parent strains, the quinolone-resistant mutant (GyrA S83L)
showed a fourfold increased albicidin resistance (Fig. 5A),
whereas the CcdB-resistant mutant (GyrA R462C) showed a
twofold increased albicidin sensitivity (Fig. 5B). S83L is close
to the GyrA catalytic site for DNA cleavage and confers ap-
proximately 20-fold increased resistance to various quinolones,
accompanied by decreased drug binding to the gyrase-DNA
complex (21). R462 is in the central dimerization domain of
GyrA, which also forms the exit gate in the A2B2 holoenzyme,
and it stacks with W99 of CcdB to anchor this peptide poison
as a wedge that holds the catalytic domain of gyrase in its open
configuration (19). The R462C mutation confers high-level
resistance to CcdB and blocks CcdB binding to gyrase (5, 18,
39). The conformational changes during the gyrase catalytic
cycle have yet to be fully elucidated, and it is not apparent how
a small molecule such as albicidin could simultaneously inter-
act with the catalytic and the dimerization regions of GyrA.
One or both of the mutations may affect the sensitivity to
albicidin indirectly, for example, by altering the duration of the
proposed ATP-mediated, albicidin-sensitive conformation
during the catalytic cycle.
Self-protection against albicidin. Antibiotics that stabilize
the gyrase-cleaved DNA complex rapidly stop bacterial multi-
plication by blocking DNA replication (45), as previously ob-
served for albicidin (10). Cell death probably involves DNA
fragmentation at the unsealed DNA cleavage sites (27). It is
not surprising that X. albilineans uses multiple self-protection
mechanisms against this potent bactericide, including highly
regulated biosynthesis (50) and efficient export (14). To these
we can now add coordinated production with albicidin biosyn-
thesis enzymes of a DNA-mimicking pentapeptide repeat pro-
tein that binds to DNA gyrase in competition with DNA (23)
and protects DNA gyrase from inhibition by albicidin. This
protein (AlbG) increases the resistance of E. coli DNA gyrase
to albicidin both in vivo (Fig. 5C) and in vitro, and at higher
concentrations it inhibits supercoiling by the E. coli gyrase in
the absence of albicidin. In contrast to some other producers of
gyrase-inhibiting antibiotics (20), there is no evidence of any
resistant gyrase subunit in the antibiotic biosynthesis gene clus-
ter (36). It will be interesting to examine the X. albilineans
gyrase genes in the future and to determine the sensitivity of
the X. albilineans gyrase both to albicidin and to AlbG.
Opportunity of a new class of gyrase-inhibiting antibiotics.
Given the evidence that albicidin is a potent gyrase inhibitor
with action at the molecular level different from those of
known antibiotic classes, further characterization of the struc-
ture and action of albicidin coupled with the growing insight
into the albicidin biosynthetic machinery may open the possi-
bility of a new family of antibacterial drugs.
ACKNOWLEDGMENTS
This work was supported by a University of Queensland scholarship
and travel funds for S.M.H.; work in A.M.’s laboratory was supported
by BBRSC and the EU.
REFERENCES
1. Barnard, F. M., and A. Maxwell. 2001. Interaction between DNA gyrase and
quinolones: effects of alanine mutations at GyrA subunit residues Ser83 and
Asp87. Antimicrob. Agents Chemother. 45:1994–2000.
2. Basnayake, W. V. S., and R. G. Birch. 1995. A gene from Alcaligenes deni-
trificans that confers albicidin resistance by reversible antibiotic binding.
Microbiology 141:551–560.
3. Bates, A. D., M. H. Odea, and M. Gellert. 1996. Energy coupling in Esche-
richia coli DNA gyrase: the relationship between nucleotide binding, strand
passage, and DNA supercoiling. Biochemistry 35:1408–1416.
4. Bernard, P. 1995. New ccdB positive-selection cloning vectors with kanamy-
cin or chloramphenicol selectable markers. Gene 162:159–160.
5. Bernard, P., and M. Couturier. 1992. Cell killing by the F plasmid CcdB
protein involves poisoning of DNA-topoisomerase II complexes. J. Mol.
Biol. 226:735–745.
6. Birch, R. G. 2001. Xanthomonas albilineans and the antipathogenesis ap-
proach to disease control. Mol. Plant Pathol. 2:1–11.
7. Birch, R. G., and S. S. Patil. 25 June 1985. Antibiotic and process for the
production thereof. U.S. patent 4525354.
8. Birch, R. G., and S. S. Patil. 1987. Correlation between albicidin production
and chlorosis induction by Xanthomonas albilineans, the sugarcane leaf scald
pathogen. Physiol. Mol. Plant Pathol. 30:199–206.
9. Birch, R. G., and S. S. Patil. 1987. Evidence that an albicidin-like phytotoxin
induces chlorosis in sugarcane leaf scald disease by blocking plastid DNA
replication. Physiol. Mol. Plant Pathol. 30:207–214.
10. Birch, R. G., and S. S. Patil. 1985. Preliminary characterization of an anti-
biotic produced by Xanthomonas albilineans which inhibits DNA synthesis in
Escherichia coli. J. Gen. Microbiol. 131:1069–1075.
11. Birch, R. G., and S. S. Patil. 1983. The relation of blocked chloroplast
differentiation to sugarcane leaf scald disease. Phytopathology 73:1368–1374.
12. Birch, R. G., J. M. Pemberton, and W. V. S. Basnayake. 1990. Stable albicidin
resistance in Escherichia coli involves an altered outer membrane nucleoside
uptake system. J. Gen. Microbiol. 136:51–58.
13. Bolivar, F., and K. Backman. 1979. Plasmids of Escherichia coli as cloning
vectors. Methods Enzymol. 68:245–267.
14. Bostock, J. M., G. Huang, S. M. Hashimi, L. H. Zhang, and R. G. Birch.
2006. A DHA14 drug efflux gene from Xanthomonas albilineans confers
high-level albicidin antibiotic resistance in Escherichia coli. J. Appl. Micro-
biol. 101:151–160.
15. Cho, H. S., S. S. Lee, K. D. Kim, I. Hwang, J. S. Lim, Y. I. Park, and H. S.
186 HASHIMI ET AL. ANTIMICROB. AGENTS CHEMOTHER.
 o
n
 O
ctober 21, 2015 by UQ Library
http://aac.asm
.org/
D
ow
nloaded from
 
Pai. 2004. DNA gyrase is involved in chloroplast nucleoid partitioning. Plant
Cell 16:2665–2682.
16. Contreras, A., and A. Maxwell. 1992. GyrB mutations which confer coumarin
resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia
coli DNA gyrase. Mol. Microbiol. 6:1617–1624.
17. Corbett, K. D., and J. M. Berger. 2004. Structure, molecular mechanisms,
and evolutionary relationships in DNA topoisomerases. Annu. Rev. Biophys.
Biomol. Struct. 33:95–118.
18. Critchlow, S. E., M. H. O’Dea, A. J. Howells, M. Couturier, M. Gellert, and
A. Maxwell. 1997. The interaction of the F plasmid killer protein, CcdB, with
DNA gyrase: induction of DNA cleavage and blocking of transcription. J.
Mol. Biol. 273:826–839.
19. Dao-Thi, M. H., L. VanMelderen, E. De Genst, H. Afif, L. Buts, L. Wyns, and
R. Loris. 2005. Molecular basis of gyrase poisoning by the addiction toxin
CcdB. J. Mol. Biol. 348:1091–1102.
20. Flatman, R. H., A. J. Howells, L. Heide, H. P. Fiedler, and A. Maxwell. 2005.
Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.
Antimicrob. Agents Chemother. 49:1093–1100.
21. Heddle, J., and A. Maxwell. 2002. Quinolone-binding pocket of DNA gyrase:
role of GyrB. Antimicrob. Agents Chemother. 46:1805–1815.
22. Heddle, J. G., F. M. Barnard, L. M. Wentzell, and A. Maxwell. 2000. The
interaction of drugs with DNA gyrase: a model for the molecular basis of
quinolone action. Nucleosides Nucleotides Nucleic Acids 19:1249–1264.
23. Hegde, S. S., M. W. Vetting, S. L. Roderick, L. A. Mitchenall, A. Maxwell,
H. E. Takiff, and J. S. Blanchard. 2005. A fluoroquinolone resistance protein
from Mycobacterium tuberculosis that mimics DNA. Science 308:1480–1483.
24. Huang, G., L. Zhang, and R. G. Birch. 2000. Albicidin antibiotic and
phytotoxin biosynthesis in Xanthomonas albilineans requires a phospho-
pantetheinyl transferase gene. Gene 258:193–199.
25. Huang, G., L. Zhang, and R. G. Birch. 2000. Analysis of the genes flanking
xabB: a methyltransferase gene is involved in albicidin biosynthesis in
Xanthomonas albilineans. Gene 255:327–333.
26. Huang, G., L. Zhang, and R. G. Birch. 2001. A multifunctional polyketide-
peptide synthase for albicidin biosynthesis in Xanthomonas albilineans. Mi-
crobiology 147:631–642.
27. Malik, M., X. Zhao, and K. Drlica. 2006. Lethal fragmentation of bacterial
chromosomes mediated by DNA gyrase and quinolones. Mol. Microbiol.
61:810–825.
28. Maxwell, A. 1997. DNA gyrase as a drug target. Trends Microbiol. 5:102–
109.
29. Maxwell, A., and D. M. Lawson. 2003. The ATP-binding site of type II
topoisomerases as a target for antibacterial drugs. Curr. Top. Med. Chem.
3:283–303.
30. Mizushina, Y., S. Kamisuki, N. Kasai, N. Shimazaki, M. Takemura, H.
Asahara, S. Linn, S. Yoshida, A. Matsukage, O. Koiwai, F. Sugawara, H.
Yoshida, and K. Sakaguchi. 2002. A plant phytotoxin, solanapyrone A, is an
inhibitor of DNA polymerase beta and lambda. J. Biol. Chem. 277:630–638.
31. Monteiro-Vitorello, C. B., L. E. A. Camargo, M. A. Van Sluys, J. P. Kitajima,
D. Truffi, A. M. do Amaral, R. Harakava, J. C. F. de Oliveira, D. Wood, M. C.
de Oliveira, C. Miyaki, M. A. Takita, A. C. R. da Silva, L. R. Furlan, D. M.
Carraro, G. Camarotte, N. F. Almeida, H. Carrer, L. L. Coutinho, H. A.
El-Dorry, M. I. T. Ferro, P. R. Gagliardi, E. Giglioti, M. H. S. Goldman,
G. H. Goldman, E. T. Kimura, E. S. Ferro, E. E. Kuramae, E. G. M. Lemos,
M. V. F. Lemos, S. M. Z. Mauro, M. A. Machado, C. L. Marino, C. F. Menck,
L. R. Nunes, R. C. Oliveira, G. G. Pereira, W. Siqueira, A. A. de Souza, S. M.
Tsai, A. S. Zanca, A. J. G. Simpson, S. M. Brumbley, and J. C. Setubal. 2004.
The genome sequence of the gram-positive sugarcane pathogen Leifsonia xyli
subsp. xyli. Mol. Plant-Microbe Interact. 17:827–836.
32. Montero, C., G. Mateu, R. Rodriguez, and H. Takiff. 2001. Intrinsic resis-
tance of Mycobacterium smegmatis to fluoroquinolones may be influenced by
new pentapeptide protein MfpA. Antimicrob. Agents Chemother. 45:3387–
3392.
33. Pierrat, O. A., and A. Maxwell. 2003. The action of the bacterial toxin
microcin B17—insight into the cleavage-religation reaction of DNA gyrase.
J. Biol. Chem. 278:35016–35023.
34. Pierrat, O. A., and A. Maxwell. 2005. Evidence for the role of DNA strand
passage in the mechanism of action of microcin B17 on DNA gyrase. Bio-
chemistry 44:4204–4215.
35. Reece, R. J., and A. Maxwell. 1989. Tryptic fragments of the Escherichia coli
DNA gyrase A protein. J. Biol. Chem. 264:19648–19653.
36. Royer, M., L. Costet, E. Vivien, M. Bes, A. Cousin, A. Damais, I. Pieretti, A.
Savin, S. Megessier, M. Viard, R. Frutos, D. W. Gabriel, and P. C. Rott.
2004. Albicidin pathotoxin produced by Xanthomonas albilineans is encoded
by three large PKS and NRPS genes present in a gene cluster also containing
several putative modifying, regulatory, and resistance genes. Mol. Plant-
Microbe Interact. 17:414–427.
37. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory
manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor,
NY.
38. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain
termination inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
39. Smith, A. B., and A. Maxwell. 2006. A strand-passage conformation of DNA
gyrase is required to allow the bacterial toxin, CcdB, to access its binding site.
Nucleic Acids Res. 34:4667–4676.
40. Steinberg, T. H., and R. R. Burgess. 1992. Tagetitoxin inhibition of RNA
polymerase III transcription results from enhanced pausing at discrete sites
and is template dependent. J. Biol. Chem. 267:20204–20211.
41. Tran, J. H., and G. A. Jacoby. 2002. Mechanism of plasmid-mediated quin-
olone resistance. Proc. Natl. Acad. Sci. USA 99:5638–5642.
42. Walker, M. J., R. G. Birch, and J. M. Pemberton. 1988. Cloning and char-
acterization of an albicidin resistance gene from Klebsiella oxytoca. Mol.
Microbiol. 2:443–454.
43. Wall, M. K., and R. G. Birch. 1997. Genes for albicidin biosynthesis and
resistance span at least 69 kb in the genome of Xanthomonas albilineans.
Lett. Appl. Microbiol. 24:256–260.
44. Wall, M. K., L. A. Mitchenall, and A. Maxwell. 2004. Arabidopsis thaliana
DNA gyrase is targeted to chloroplasts and mitochondria. Proc. Natl. Acad.
Sci. USA 101:7821–7826.
45. Wentzell, L. M., and A. Maxwell. 2000. The complex of DNA gyrase and
quinolone drugs on DNA forms a barrier to the T7 DNA polymerase rep-
lication complex. J. Mol. Biol. 304:779–791.
46. Williams, N. L., A. J. Howells, and A. Maxwell. 2001. Locking the ATP-
operated clamp of DNA gyrase: probing the mechanism of strand passage. J.
Mol. Biol. 306:969–984.
47. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone
resistance-determining region in the DNA gyarse gyrA gene of Escherichia
coli. Antimicrob. Agents Chemother. 34:1271–1272.
48. Zhang, L., and R. G. Birch. 1997. The gene for albicidin detoxification from
Pantoea dispersa encodes an esterase and attenuates pathogenicity of Xan-
thomonas albilineans to sugarcane. Proc. Natl. Acad. Sci. USA 94:9984–9989.
49. Zhang, L., J. Xu, and R. G. Birch. 1999. Engineered detoxification confers
resistance against a pathogenic bacterium. Nat. Biotechnol. 17:1021–1024.
50. Zhang, L., J. Xu, and R. G. Birch. 1998. Factors affecting biosynthesis by
Xanthomonas albilineans of albicidin antibiotics and phytotoxins. J. Appl.
Microbiol. 85:1023–1028.
VOL. 51, 2007 ALBICIDIN AS AN INHIBITOR OF DNA GYRASE 187
 o
n
 O
ctober 21, 2015 by UQ Library
http://aac.asm
.org/
D
ow
nloaded from
 
